Endovia Health Sciences EDVA
NYSE EDVA
$0.26 +0.00 (+0.00%)
As of: Sep 3, 2026 · 11:52 AM EDT

Endovia Health Sciences (EDVA) Short term Debt (2012 - 2023)

Analysis

Endovia Health Sciences (EDVA) Short term Debt (2012 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.50 Bn 133.65 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.53 Bn 78.54 Bn 3.93 Bn
3 Argenx Se 65.05 Bn 59.86 Bn 1.37 Bn
4 Moderna 57.11 Bn 51.98 Bn 52.00 Mn
5 Revolution Medicines 44.71 Bn 44.71 Bn -
6 BeOne Medicines 40.40 Bn 35.31 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.36 Bn 32.05 Bn 992.69 Mn
8 Royalty Pharma 28.16 Bn 27.32 Bn -
9 Insmed 27.40 Bn 26.24 Bn 358.27 Mn
10 Endovia Health Sciences 801,166.21 558,464.21 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 91,800.00
Dec 31, 2022 91,800.00
Sep 30, 2022 1.16 Mn
Sep 30, 2021 100,000.00
Jun 30, 2021 100,000.00
Mar 31, 2021 100,000.00
Dec 31, 2020 100,000.00
Sep 30, 2020 100,000.00
Jun 30, 2020 100,000.00
Mar 31, 2020 100,000.00
Dec 31, 2019 2.20 Mn
Sep 30, 2019 3,122.00
Jun 30, 2019 4,491.00
Mar 31, 2019 5,926.00
Dec 31, 2018 8,241.00
Sep 30, 2018 10,265.00
Jun 30, 2018 10,442.00
Mar 31, 2018 11,043.00
Dec 31, 2017 11,296.00
Sep 30, 2017 10,973.00